4//SEC Filing
Brennan Nora 4
Accession 0001209191-22-039057
CIK 0000831547other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 7:56 PM ET
Size
9.7 KB
Accession
0001209191-22-039057
Insider Transaction Report
Form 4
Brennan Nora
Director
Transactions
- Award
Common Stock, $0.001 par value
2022-06-21+334,507→ 363,784 total - Sale
Common Stock, $0.001 par value
2022-06-21$0.79/sh−3,569$2,802→ 360,215 total - Award
Stock Option (Right to Buy)
2022-06-21+1,515,957→ 1,515,957 totalExercise: $0.71Exp: 2032-05-25→ Common Stock (1,515,957 underlying)
Footnotes (4)
- [F1]The restricted stock unit grant was approved by Spectrum Pharmaceuticals, Inc's ("Spectrum") board of directors on May 25, 2022, subject to stockholder approval of the Amended and Restated 2018 Long-Term Incentive Plan (the "Plan") under which the restricted stock unit was granted. Spectrum's stockholders approved the Plan on June 21, 2022.
- [F2]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
- [F3]The option grant was approved by Spectrum's board of directors on May 25, 2022, subject to stockholder approval of the Plan under which the option was granted. Spectrum's stockholders approved the Plan on June 21, 2022.
- [F4]One third of the aggregate amount of option shares shall vest on each of May 25, 2023, 2024 and 2025, respectively.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeother
Related Parties
1- filerCIK 0001790215
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 7:56 PM ET
- Size
- 9.7 KB